Home » Authors » Glen Harris

Glen Harris

Articles

ARTICLES

Medicines Co. Snares HDL Drug in Potential $410M Pfizer Deal

Nov. 1, 2011

No Abstract

Kosan Cuts Staff, Adds CEO and Focuses on its Pipeline

Nov. 1, 2011

No Abstract

PDL Divestiture Continues in $170M Deal with EKR

Nov. 1, 2011

No Abstract

Phenomix Seeking $86M IPO to Push Diabetes Candidate

Nov. 1, 2011

No Abstract

Regeneron Signs Another Deal For A Potential $120M Payoff

Nov. 1, 2011

No Abstract

Arginetix, Immune Control Merge Two Corridors in Vascular Space

June 18, 2010

Alvine Brings in Another $21M to Fund Celiac Disease Studies

Sep. 16, 2009

NPS Boosts Treasury with $40M Equity Financing for Pivotal Trials

Aug. 7, 2009

Infinity Halts Tumor Trial Due to High Mortality Data

April 16, 2009

Lean Sunesis Gets Flush with $43.5M Placement

April 2, 2009

View All Articles by Glen Harris

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...